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Bovine necrohemorrhagic enteritis is a major cause of mortality in veal calves. Clostridium perfringens is considered
as the causative agent, but there has been controversy on the toxins responsible for the disease. Recently, it has
been demonstrated that a variety of C. perfringens type A strains can induce necrohemorrhagic lesions in a calf
intestinal loop assay. These results put forward alpha toxin and perfringolysin as potential causative toxins, since
both are produced by all C. perfringens type A strains. The importance of perfringolysin in the pathogenesis of
bovine necrohemorrhagic enteritis has not been studied before. Therefore, the objective of the current study was
to evaluate the role of perfringolysin in the development of necrohemorrhagic enteritis lesions in calves and its
synergism with alpha toxin. A perfringolysin-deficient mutant, an alpha toxin-deficient mutant and a perfringolysin
alpha toxin double mutant were less able to induce necrosis in a calf intestinal loop assay as compared to the
wild-type strain. Only complementation with both toxins could restore the activity to that of the wild-type. In
addition, perfringolysin and alpha toxin had a synergistic cytotoxic effect on bovine endothelial cells. This
endothelial cell damage potentially explains why capillary hemorrhages are an initial step in the development of
bovine necrohemorrhagic enteritis. Taken together, our results show that perfringolysin acts synergistically with
alpha toxin in the development of necrohemorrhagic enteritis in a calf intestinal loop model and we hypothesize
that both toxins act by targeting the endothelial cells.Introduction
Since the ban on antimicrobial growth promoters in
Europe, necrohemorrhagic enteritis emerged as a major
cause of mortality in veal calves in Belgium, causing im-
portant economic losses [1-3]. Bovine necrohemorrhagic
enteritis, also known as enterotoxaemia, is most typically
characterized by sudden death and macroscopic post-
mortem findings are necrotic and hemorrhagic lesions
in the small intestine [4,5]. Microscopically, necrosis of
the intestinal mucosa and hemorrhages are observed
[1,5,6]. Clostridium perfringens is considered as the* Correspondence: filip.vanimmerseel@ugent.be
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distribution, and reproduction in any mediumcausative agent [1,7]. This spore-forming, Gram-positive,
anaerobic bacterium is often found as a normal inhabit-
ant of the intestine of most animal species and humans
[6,8,9]. For reasons that are not yet fully understood, C.
perfringens can, under certain predisposing conditions,
proliferate rapidly, concurrently produce toxins and
cause disease. Stress, for example, is considered to be
such a predisposing factor, and also the feed compos-
ition is believed to be of major importance for the devel-
opment of the disease [7,10,11]. The presence of a
causative toxin determines the potential of a C. per-
fringens strain to cause lesions in several animal species.
Classification of C. perfringens strains is based on the
production of four major toxins, namely alpha, beta,
epsilon and iota toxin. In addition to the major toxins,Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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perfringolysin [5,12].
There has been controversy on the toxins responsible
for bovine necrohemorrhagic enteritis. Some studies
proposed epsilon toxin as a possible causative toxin
[13-16]. This toxin is produced by type B and D strains
and plays a key role in the pathogenesis of sheep and
goat enterotoxaemia. Filho et al. could indeed induce
clinical signs and lesions, when a type D strain was inoc-
ulated intraduodenally in a calf [15]. In an intestinal loop
assay comparing alpha and epsilon toxin, only epsilon
toxin was able to cause severe oedema and hemorrhages
in the lamina propria [9]. These results point to epsilon
toxin as causative toxin. More recently, beta2-toxin
(CPB2) has been linked to necrohemorrhagic enteritis in
calves and cows [2,6,17-19]. Manteca et al. showed that
inoculating a beta2-positive type A strain into a bovine
ligated intestinal loop caused hemorrhages of the intes-
tinal wall and necrosis [19]. The strain however also
produced high levels of alpha toxin, so a synergistic
action between both toxins was proposed. Moreover,
allelic variants of the CPB2-gene have been identified
and strains from cattle mostly carried the atypical CPB2-
gene that is not expressed, in contrast to the “consensus”
variant [2,6,17]. In addition, a more recent study isolated
only beta2-negative type A strains from calves with
necrohemorrhagic enteritis and these strains were also
able to induce pathological changes in inoculated intes-
tinal loops [10]. We recently developed an experimental
intestinal loop model that mimics the typical lesions of
calf necrohemorrhagic enteritis both macroscopically
and microscopically [20]. In this model, it was demon-
strated that type A strains from bovine and non-bovine
origin, including both beta2-negative and -positive strains,
were able to induce necrohemorrhagic lesions [20]. These
results suggest that the causative toxin should be present
in all the tested C. perfringens strains. This puts forward a
potential role for alpha toxin and perfringolysin, since
both are produced by nearly all C. perfringens strains [21].
The importance of perfringolysin in the pathogenesis of
bovine necrohemorrhagic enteritis is not reported before.Table 1 Description of strains and toxin activities in supernat
Straina Strainnumber Relevant characteristic
Wild-type JIR325 Strain 13d
ΔpfoAΔplc JIR4444
JIR325 pfoA::ermB plcΩpJIR
suicide plasmid
pfoA-complemented ΔpfoAΔplc JIR4460 JIR4444(pJIR871), CmR
plc-complemented ΔpfoAΔplc JIR4461 JIR4444(pJIR1642), Cm
double-complemented
ΔpfoAΔplc
JIR4462 JIR4444(pJIR1720), Cm
apfoA: perfringolysin gene, plc : alpha toxin gene, bCmr: chloramphenicol resistant, c
resistant derivative of strain 13, a gas gangrene strain.In gas gangrene or clostridial myonecrosis, perfringolysin
is involved in the pathogenesis in synergy with alpha toxin
[22-24]. Additionally, Valgaeren et al. observed that the
early pathogenesis of calf necrohemorrhagic enteritis in an
experimental loop assay is characterized by congestion of
the capillaries resulting in hemorrhages and finally necro-
sis of the mucosa [20]. This points to the endothelium as
a possible target.
Therefore, the objective of the present study was to
evaluate the role of perfringolysin in the development of
necrohemorrhagic enteritis and its synergism with alpha
toxin in calves, by using a calf intestinal loop assay and
endothelial cell cytotoxicity assays.
Materials and methods
Bacterial strains and culture conditions
The bacterial strains used were a wild-type gas gangrene
strain (JIR325) and its isogenic mutant genetically defi-
cient in the production of perfringolysin and alpha toxin
(ΔpfoA Δplc double mutant JIR4444) as well as the ΔpfoA
Δplc double mutant complemented with a plasmid that
carried either the perfringolysin gene (pfoA-comple-
mented ΔpfoA Δplc mutant JIR4460) or the alpha toxin
gene (plc-complemented ΔpfoA Δplc mutant JIR4461) or
both toxins (pfoA plc double-complemented ΔpfoA Δplc
mutant JIR4462) (Table 1) [23,25]. All strains were kindly
provided by J.I. Rood (Department of Microbiology,
Monash University, Clayton, Victoria, Australia). The
strains were grown at 37 °C in Brain Heart Infusion (BHI)
broth (Oxoid, Basingstoke, United Kingdom) with 0.375%
glucose in an anaerobic (84% N2, 8% CO2 and 8% H2)
cabinet (Ruskinn Technology, Bridgend, UK). When re-
quired, chloramphenicol (30 μg/mL) was added to the
growth media. The supernatants were filter-sterilized over
a 0.2 μM filter before use in the experiments (Merck
Millipore, Billerica, Massachusetts). When a logarithmic-
phase culture was used, a 1/100 dilution from an over-
night culture was made 3 h prior to use and was incubated
in an anaerobic cabinet.
Filter-sterilized supernatant of an overnight culture of
each strain was assayed for perfringolysin activity by theants of an overnight culture
sb Plasmid-encoded toxin gene(s)a
Plc activity
(μg mL-1)c
PFO activity
(log2(titre))
c Ref.
12.5 ± 2.5 4.8 ± 0.2 [25]
1774,
< 1.0 < 1.0 [23]
pfoA+ < 1.0 4.1 ± 0.3 [23]
R plc+ 6.8 ± 0.7 < 1.0 [23]
R pfoA+plc+ 8.0 ± 0.5 3.5 ± 0.1 [23]
Plc : alpha toxin, PFO: perfringolysin O, dJIR325 is a rifampicin and nalidixic acid
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cells as described previously (Table 1) [26]. The per-
fringolysin activity was expressed as the reciprocal of the
last dilution which showed complete hemolysis. The
perfringolysin assay was performed in triplicate. For the
detection of alpha toxin in the supernatant, the Bio-
X Alpha Toxin Elisa Kit (Bio-X Diagnostics, Jemelle,
Belgium) was used according to the instructions of the
manufacturer (Table 1). The amount of alpha toxin was
calculated as described previously in μg mL-1 [27]. The
alpha toxin ELISA was performed in triplicate.
Assessing the role of perfringolysin by using an intestinal
loop model
The animal studies were undertaken with approval
(EC2012_056) of the Ethical Committee of the Faculty
of Veterinary Medicine (Ghent University). Three 11-
week-old Holstein Friesian calves, originating from a
commercial veal herd, were used. Intestinal loop assays
were conducted as described by Valgaeren et al. [20].
Briefly, the calves were anesthetized and the small intes-
tine was exteriorized. Intestinal loops were ligated and
injected with 20 mL logarithmic cultures followed by
an injection of 10 mL 25% commercial milk replacer
(Vitaspray, Vitamex®, Drongen, Belgium) suspended in
sterile 0.9% NaCl solution. Because the gas gangrene
strain JIR325 could induce lesions comparable to the
bovine strains, this strain was used in combination with
its isogenic mutants (Table 1) [20]. Each strain was
injected in quintuplicate and as a control BHI was injected
in five loops instead. After injection of the loops, the
abdomen was closed and the calves were maintained
under anesthesia. At 6-h post-inoculation the animals
were euthanized and samples were taken. Samples were
fixed in 4% phosphate buffered formaldehyde. They were
embedded in paraffin wax, sectioned and stained with
hematoxylin-eosin by the conventional method for histo-
logical examination. The sections were evaluated for pres-
ence of necrotic lesions (Leica DM L2 microscope with
Leica DFC320 camera and LAS software).
Isolation of bovine umbilical vein endothelial cells
Primary bovine umbilical vein endothelial cells (BUVEC)
were isolated from umbilical cord veins by an adaptation
of the method of Jaffe et al. [28]. Umbilical cords
obtained from calves born by caesarean section, were
transported in 0.9% HBSS-HEPES buffer (pH 7.4, Gibco,
Grand Island, NY, USA) supplemented with 500 U/mL
penicillin (Sigma-Aldrich) and 50 μg/mL streptomycin
(Sigma-Aldrich). The umbilical vein was cannulated and
flushed with pre-warmed (37 °C) HBSS (Gibco, Grand
Island, NY, USA). 0.5% collagenase type IV (Sigma-Al-
drich) suspended in HBSS was infused into the lumen of
the clamped shut umbilical vein and it was incubated for30 min at 37 °C. After gently massaging the umbilical
vein, the cells were flushed from the vein by perfusion
with 10 mL HBSS containing 20% fetal calf serum (FCS,
Bockneck Labs Inc., Toronto, Canada). After rinsing
(250 × g, 5 min), a single cell suspension was obtained
by filtration through a 70 μm cell strainer (BD Labware,
San Jose, CA, USA). The pelleted (250 × g, 10 min) cells
were resuspended in endothelial cell growth medium
containing 20% FCS (EGM-2; Lonza, Basel, Switzerland)
and seeded in 25 cm2 plastic tissue culture flasks. After
24 h incubation at 37 °C in the presence of 5% CO2, the
cell medium was changed. Bovine umbilical vein endo-
thelial cells were grown to confluence. The endothelial
origin and purity was verified by immunocytochemistry
using anti-mouse CD31 antibody (Dako, Heverlee,
Belgium).Assessing the cytotoxic effects of perfringolysin on
bovine endothelial cells
In order to visually assess cytotoxicity, BUVEC were
seeded on 13-mm-circular glass slides (VWR Inter-
national BVBA, Leuven, Belgium) in a 24-well plate at a
concentration of 1 × 105 cells/mL and were incubated at
37 °C in the presence of 5% CO2. After 36 h, the cells
were exposed to 3% filter-sterilized supernatant of an
overnight culture diluted in serum-free endothelial cell
growth medium (SFM). The strains used for producing
the supernatants were the wild-type strain JIR325 and its
isogenic mutants (Table 1). SFM was used as a control.
After 1.5 h incubation, the cells were rinsed three times
with HBSS containing Ca2+ and Mg2+. They were fixed
with 100% methanol and stained with Haemacolor-
stain (Merck, Darmstadt, Germany). The glass slides
were mounted on a microscope slide and observed
microscopically.
To quantify the cytotoxicity, BUVEC were seeded in a
96-well plate at a concentration of 1 × 105 cells/mL and
incubated for 36 h as described above. 1% or 6% of the
above mentioned supernatants in SFM was added to the
cells. SFM was used to determine reference values. After
1.5 h incubation, a Neutral Red Uptake Assay was
performed [29]. Briefly, Neutral Red Medium (EGM-
2 medium containing neutral red (Merck N.V./S.A.,
Overijse, Belgium)) was added to the cells and the plates
were incubated at 37 °C. After 3 h of incubation, the
cells were rinsed with HBSS containing Ca2+ and Mg2+
and treated with extracting solution (50% absolute etha-
nol, 49% distilled water and 1% glacial acetic acid) for
15 min at room temperature on a shaker to extract the
neutral red from the cells. The absorbance was deter-
mined at 550 nm and cell viability was expressed as the
percentage of viable cells compared to untreated cells
(negative control) and cells treated with the supernatant
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natant was tested in duplicate in three independent
assays.Statistical analysis
Significant differences in the number of loops with ne-
crosis between the wild-type and the mutants were
determined using a two-tailed Fisher Exact test (P <
0.05). Significant differences between the relative via-
bility of the mutants and 0%, which corresponds with
the relative viability of the wild-type strain, were in-
vestigated using a two-tailed Wilcoxon signed rank
test (P < 0.05). A one-way analysis of variance (ANOVA)
with the post hoc Tukey-Kramer multiple-comparison
test was used to identify significant differences in the
relative viability of cells after contact with the super-
natants of the mutants (P < 0.001). All statistical ana-
lyses were performed using GraphPad Prism Software
5.0 (GraphPad Software, Inc., USA).Figure 1 Histological section from an intestinal loop inoculated
with wild-type. Hematoxylin and eosin stained histological section
from an intestinal loop inoculated with a logarithmic culture of the
wild-type strain and milk replacer, sampled after 6 h incubation.
Arrows indicate the demarcation of the necrosis of the villus tip with
loss of epithelial cells. Also capillary congestion (1) and hemorrhage
(2) are present.
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Figure 2 Number of loops with necrosis for wild-type and
isogenic mutants. The graph shows the total number of loops in
which necrosis was present, evaluated 6 h after inoculation with a
logarithmic-phase culture of the wild-type strain (WT), ΔpfoA Δplc
mutant (ΔpfoA Δplc), pfoA-complemented ΔpfoA Δplc mutant
(pfoA-c.), plc-complemented ΔpfoA Δplc mutant (plc-c.),
double-complemented ΔpfoA Δplc mutant (double-c.) and BHI as a
control in three calf intestinal loop assays. Each strain was inoculated
in quintuplicate. A significant difference was found between the
wild-type and the ΔpfoA Δplc double mutant (P < 0.01) and the
pfoA-complemented ΔpfoA Δplc mutant (P < 0.01).Results
Assessing the role of perfringolysin by using an intestinal
loop model
Histological examination of loops inoculated with the
wild-type strain showed necrosis of the tips of the villi
and congestion of the capillaries and hemorrhages in the
underlying viable tissue (Figure 1). Rod-shaped bacteria
were found attached to cellular debris in the lumen and
to the mucosa. To elucidate the relative contribution of
perfringolysin and alpha toxin in the induction of
necrohemorrhagic enteritis a wild-type strain and its
ΔpfoA Δplc mutant was used in combination with the
ΔpfoA Δplc mutant complemented with either the pfoA
or the plc gene or both (Figure 2). Using the same intes-
tinal loop model, Valgaeren et al. observed mucosal
hemorrhages, not only in the challenge strain inoculated
loops, but also in some control loops. Necrosis only
occured after inoculation of a C. perfringens strain [20].
Therefore, in the present study we focussed on the pres-
ence of necrosis to compare the mutants with the wild-
type strain. Significantly fewer loops injected with the
ΔpfoA Δplc mutant or the pfoA-complemented ΔpfoA
Δplc mutant (or plc-deficient strain) showed necrosis in
comparison to the wild-type strain (P < 0.01). The plc-
complemented ΔpfoA Δplc mutant (or pfoA-deficient
strain) could induce necrotic lesions in fewer loops as
compared to the wild-type strain, but the difference in
number of necrotic loops did not reach statistical signifi-
cance. The double-complemented ΔpfoA Δplc mutant
showed necrosis in as many loops as the wild-type.
Apparently, only the complementation of both toxins
could restore the activity to that of the wild-type. In the
control loops no necrotic lesions were detected.
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Figure 4 Effect of the supernatant of wild-type and isogenic
mutants on the viability of bovine umbilical vein endothelial
cells. The graph shows the percentage of viable cells relative to
viable untreated cells (negative control) and cells treated with
supernatant of the wild-type strain (positive control) after 1.5 h
incubation with 6 and 1% supernatant of ΔpfoA Δplc double mutant
(ΔpfoA Δplc), pfoA-complemented ΔpfoA Δplc mutant
(pfoA-c.), plc-complemented ΔpfoA Δplc mutant (plc-c.) and
double-complemented ΔpfoA Δplc mutant (double-c.). The values
are the average of three independent experiments conducted in
duplicate with error bars representing the standard deviations (SD).
Asterisks indicate significant difference between that strain and all
other strains for each concentration (p < 0.001).
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bovine endothelial cells
To determine whether perfringolysin and alpha toxin
have cytotoxic effects on endothelial cells, bovine umbil-
ical cord endothelial cells were exposed to supernatant
of a wild-type strain and its isogenic mutants. Almost all
cells detached after exposure to supernatant of the wild-
type strain (Figure 3). No cytotoxicity could be observed
visually when using the supernatant of the ΔpfoA Δplc
mutant as compared to the control. The supernatants of
the pfoA-complemented Δpfo Δplc mutant and the
plc-complemented Δplc Δpfo mutant were less cytotoxic
in comparison with supernatant of the wild-type strain,
but more cytotoxic as compared to supernatant of the
Δplc Δpfo mutant. Complementation of the Δplc Δpfo
mutant with both the plc and pfo gene restored cytotoxic
effects to the wild-type levels. These data indicate that
perfringolysin and alpha toxin are important factors for
cytotoxicity on bovine endothelial cells and have a syner-
gistic effect.
To quantify the relative contribution of alpha toxin
and perfringolysin on endothelial cell cytotoxicity, the
viability was assessed by a Neutral Red Uptake Assay.
The percentage viability after 1.5 h incubation with 1
and 6% supernatant of the isogenic mutants relative to
viable untreated cells (negative control) and cells treated
with supernatant of the wild-type strain (positive con-
trol) are shown in Figure 4. The cytotoxic effect of 6%
supernatant of the ΔpfoA Δplc mutant was significantly
lower than the wild-type (P < 0.05) and all other tested
strains (P < 0.001). The cytotoxicity of 1% supernatant of
ΔpfoA Δplc mutant, pfoA-complemented ΔpfoA ΔplcWT
ΔpfoA Δplc
pfoA-c.
plc-c. SFM
double-c.
Figure 3 Cytotoxic effect of the supernatant of wild-type and isogenic mutants on bovine umbilical vein endothelial cells (BUVEC.)
Photomicrograph of Haemacolor-stained cells after 1.5 h exposure to 3% supernatant of the wild-type strain (WT), ΔpfoA Δplc double mutant
(ΔpfoA Δplc), pfoA-complemented ΔpfoA Δplc mutant (pfoA-c.), plc-complemented ΔpfoA Δplc mutant (plc-c.), double-complemented ΔpfoA Δplc
mutant (double-c.) and SFM as a negative control. Magnification, ×400.
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was significantly lower as compared to that of the wild-
type (P < 0.05) and that of the double-complemented
ΔpfoA Δplc mutant (P < 0.001). These results confirm
that perfringolysin as well as alpha toxin contribute to
the cytotoxic effect of a C. perfringens culture, and show
a synergistic effect of perfringolysin and alpha toxin.
Discussion
The presence of a causative toxin in a C. perfringens
strain determines its potential to cause lesions and sub-
sequently diseases in several animal species. However,
there is still controversy on the toxin responsible for
bovine necrohemorrhagic enteritis. In a previous study,
it was demonstrated that type A strains from bovine and
non-bovine origin can induce necrohemorrhagic lesions
in a calf intestinal loop assay [20]. These results suggest
that the causative toxin is one of the toxins produced by
all C. perfringens type A strains. In the present study, it
was shown that perfringolysin and alpha toxin are
involved in the induction of necrohemorrhagic lesions.
Indeed, a plc-complemented ΔpfoA Δplc mutant (or
pfoA-deficient strain) and a pfoA-complemented ΔpfoA
Δplc mutant (or plc-deficient strain) of a gas gangrene
strain had a decreased ability to induce necrohemorrhagic
lesions in a calf intestinal loop assay. The gas gangrene
strain JIR325 was used, because perfringolysin- and alpha
toxin-deficient mutants of this strain were already avail-
able and because this strain was able to induce mucosal
hemorrhages and necrosis of the villus tips comparable to
the lesions induced by bovine strains in a calf intestinal
loop model [20]. In previous studies, it was suggested that
epsilon toxin and beta2-toxin are essential in the develop-
ment of necrosis. Filho et al. induced lesions in a calf
intraduodenally inoculated with a type D strain [15]. The
authors proposed epsilon toxin as causative toxin. How-
ever, based on our results, alpha toxin and perfringolysin
may also have been involved in lesion development, since
both toxins are produced by type D strains as well. In an
intestinal loop assay, comparing alpha and epsilon toxin,
only epsilon toxin was able to cause severe oedema and
hemorrhages in the lamina propria [9], but these authors
did not observe necrosis, in contrast to our results which
showed necrohemorrhagic lesions comparable to field
cases. Manteca et al. stated that beta2-toxin was an essen-
tial toxin, because inoculation of a beta2-positive type A
strain into a bovine ligated intestinal loop caused
necrohemorrhages of the intestinal wall [19]. However,
the strain also produced a high level of alpha toxin and
the authors proposed a synergistic effect of alpha toxin
and beta2-toxin. Since nearly all type A strains produce
perfringolysin as well, this toxin may also have been
important in the development of the lesions. In addition,
our results agree with a recent study in which only beta2-negative type A strains were isolated from calves with
necrotic enteritis and these strains were able to induce
pathologic changes when inoculated in intestinal loops
[10]. It is still possible that beta2-toxin or other toxins can
have supplementary effects.
Valgaeren et al. also found indications that endothe-
lial damage may be involved in the early stages of in-
testinal lesion development [20]. Our results suggest
perfringolysin-induced cytotoxic effects on endothelial
cells may play a potential role in the development of
necrohemorrhagic enteritis. We showed that the plc-
complemented ΔpfoA Δplc mutant (or pfoA-deficient
strain) was significantly less cytotoxic for bovine um-
bilical cord endothelial cells (BUVEC). Endothelial
cells form a vital barrier that controls the exchange of
cells, macromolecules and fluids between the vascular
lumen and the surrounding tissue. They also maintain
the normal blood flow due to their antiplatelet, anti-
coagulant and fibrinolytic properties. Disruption of the
endothelial barrier leads to increased vascular perme-
ability along with tissue edema and hemorrhage. Fur-
thermore, it augments local coagulation and vascular
thrombosis, and subsequent hypoxic tissue necrosis
[30]. In order to confirm that the endothelium is the
target cell of perfringolysin or alpha toxin in bovine
necrohemorrhagic enteritis, it would be interesting to
localize the toxin in lesions, as already been done for
beta toxin in necrotic enteritis in piglets and in a human
case [31,32]. Beta toxin has been shown to induce porcine
endothelial cell damage in vitro and to bind to endothelial
cells, and not to epithelial cells, in the gut of diseased ani-
mals, suggesting that disruption of endothelial cells plays
a role in type C enteritis [30,31,33].
Additionally, our results show that perfringolysin and
alpha toxin act synergistically in inducing BUVEC cyto-
toxicity and necrohemorrhagic lesions in a calf intestinal
loop model. In gas gangrene, perfringolysin and alpha
toxin also act synergistically [22-24,34]. Alpha toxin is a
phospholipase C that hydrolyzes phosphatidylcholine
and sphingomyelin, both of which are important constit-
uents of eukaryotic cell membranes. Perfringolysin is a
cholesterol-dependent cytolysin and oligomerizes upon
contact with cholesterol-containing membranes to form
large transmembrane pores by inserting a beta-barrel
into the membrane [24]. It has been stated that the abil-
ity of perfringolysin to perforate the membrane of target
cells, is determined by the amount of free cholesterol
molecules present [35,36]. Moe and Heuck found that
alpha toxin cleaves the phosphocholine headgroup of
phosphatidylcholine, increasing the number of free
cholesterol molecules in the membrane and by doing so,
facilitating the interaction of perfringolysin and choles-
terol [36]. This concerted action of alpha toxin and
perfringolysin may contribute to the synergistic effect
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necrohemorrhagic enteritis.
In gas gangrene, perfringolysin modulates the host
inflammatory response by upregulating leukocyte and
endothelial adhesion molecules. This causes leukocyte
accumulation within the blood vessels and inhibits the
normal influx of phagocytic cells into infected host
tissue, reducing inflammation [22,23,37]. Additionally,
alpha toxin enhances the expression of platelet adhesion
molecules, contributing to the formation of freely mov-
ing intravascular aggregates of platelets, fibrin and neu-
trophils. This leads to the obstruction of the vessels and
contributes to a decreased blood flow [34]. Gas gangrene
is characterized by tissue necrosis, thrombosis and a lack
of leukocyte infiltration at the site of infection. On the
contrary, bovine necrohemorrhagic enteritis is associated
with congestion of the capillaries, hemorrhages and
inflammation [7,10,20]. So perfringolysin and alpha toxin
appear to be involved in both diseases, but may act in a
different way. The use of mutants deficient in the pro-
duction of alpha toxin or perfringolysin in a mouse
myonecrosis model showed that alpha toxin is essential
for thrombosis formation [22,23]. Furthermore, when
rabbits were treated intravenously with recombinant
perfringolysin a vasodilatory effect and a reduced sys-
temic vascular resistance was observed. On the other
hand, in rabbits treated with recombinant alpha toxin
the vascular resistance was maintained and the arterial
pressure was reduced [23,38,39]. Altered vascular integ-
rity, but not vascular occlusion, seems to be in accordance
with the role of perfringolysin in bovine necrohemorrhagic
enteritis. This may also explain partly the inflammation
present in necrohemorrhagic enteritis as opposed to the
lack of leukocyte infiltration in gas gangrene.
Next to the toxic effect of perfringolysin on endothe-
lial cells, other effects on the gastro-intestinal mucosa
are most likely of importance in the development of
necrohemorrhagic enteritis. Indeed, before perfringolysin
can target the endothelial cells, it has to cross the epi-
thelial barrier. While cytotoxic effects of perfringolysin
and alpha toxin on intestinal epithelial cells cannot be
excluded, also other C. perfringens toxins, enzymes or
other molecules could affect the intestinal integrity.
Intestinal integrity disturbances can also be caused by C.
perfringens independent factors in the field, such as viral
and parasitological pathogens. The most well-known
example of a predisposing pathogen for necrotic enteritis
is coccidiosis in broilers [40,41], but also in calves several
infectious agents, such as coccidia, enteropathogenic bac-
teria, corona- and rotaviruses can affect the intestinal bar-
rier integrity [40-44]. In addition, certain feed components
can act as predisposing factors for the induction of gut
lesions. These include high non-starch polysaccharide
containing diets and high protein diets, the latter mostlikely feeding the auxotrophy C. perfringens has for many
amino acids [45,46]. The diet can have a direct effect on
the virulence of C. perfringens, but it can as well affect the
intestinal tract. In calves fed with milk replacing proteins
an increase in permeability of the intestinal mucosa was
observed, which caused leakage of macromolecules from
the gut into the tissues [41,47-49]. This might also facili-
tate the uptake of toxins through the epithelial barrier.
In conclusion, our study indicates that perfringolysin is
involved in the pathogenesis of bovine necrohemorrhagic
enteritis and acts synergistically with alpha toxin. We
hypothesize that both toxins may induce intestinal lesions
by targeting the endothelial cells.
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